Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.18 +0.28 (+1.12%)
Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
From Pfizer Inc.
Via Business Wire
News headline image
U.S. Households Brace for Financial Headwinds Despite Steady Inflation, New York Fed Reports
New York, NY – December 8, 2025 – A recent report from the Federal Reserve Bank of New York (New York Fed) reveals a concerning trend: U.S. households are growing increasingly pessimistic about their... 
Via MarketMinute
Topics Economy
News headline image
Government Relations and Policy Professional Kimberly Pinter Joins Bracewell's Policy Resolution Group in Washington, DC
Washington, D.C.--(Newsfile Corp. - December 8, 2025) - Bracewell LLP announced today that Kimberly J. Pinter has joined the firm's... 
Via Newsfile
News headline image
How Do Investors Really Feel About Pfizer Inc? ↗
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar ↗
Market-based odds now show an 87% chance of a rate cut. 
Via Stocktwits
Topics ETFs Economy Government
News headline image
3 Cash-Producing Stocks with Exciting Potential
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum. 
Via StockStory
News headline image
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
From Pfizer Inc.
Via Business Wire
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective. 
Via StockStory
Topics Economy
News headline image
Curious about the most active S&P500 stocks in today's session? ↗
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
News headline image
Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗
The rebound is well underway. 
Via The Motley Fool
Topics Death
News headline image
2 Headwinds Facing Pfizer Stock Going Into 2026 ↗
There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Low-Volatility Stocks with Warning Signs
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
3 Reasons PFE is Risky and 1 Stock to Buy Instead
Pfizer has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $25.67 per share while the index has gained 15.3%. 
Via StockStory
Topics Stocks
News headline image
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Report ↗
The report added that at least one of these companies expects to fulfill the multi-billion-dollar investment pledge in full by Jan. 1, 2029. 
Via Stocktwits
Topics Artificial Intelligence Government Workforce
News headline image
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,... 
Via MarketMinute
Topics Artificial Intelligence Death Intellectual Property
News headline image
NSRI Launches Critical Study into Emergent Tech for Warfighter Gamma Radiation Protection
Omaha, NE – December 3, 2025 – In a pivotal move set to redefine warfighter safety in hazardous environments, the National Strategic Research Institute (NSRI) at the University of Nebraska today... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Most active S&P500 stocks in Wednesday's session ↗
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements. 
Via Chartmill
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an... 
Via MarketMinute
News headline image
Why Anthropic’s IPO Might Just Be Juicier Than OpenAI’s ↗
Both AI giants might launch their public market offerings next year. 
Via Stocktwits
Topics Artificial Intelligence Initial Public Offering
News headline image
A Tale Told Through a Bird’s Eyes: Jessica Mann’s Uplift Reimagines How We See the Natural World
Via AB Newswire
Topics Bonds
News headline image
Most active S&P500 stocks in Tuesday's session ↗
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Via Investor Brand Network
Topics Government
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
From BioMedWire
Via GlobeNewswire
News headline image
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam. 
Via Investor's Business Daily
News headline image
2 Top Dividend Stocks to Buy Now and Hold For a Decade ↗
These healthcare leaders can make you money while you sleep. 
Via The Motley Fool
Topics Artificial Intelligence Cannabis Intellectual Property
News headline image
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
News headline image
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across... 
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
News headline image
S&P 500 Kicks Off December in the Red as Markets Rediscover Gravity: A Deep Dive into the Economic Headwinds
New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
News headline image
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. 
Via Investor's Business Daily
Topics Death
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.